Decision

Early access to medicines scheme (EAMS) scientific opinion: sacubitril/valsartan

This publication was withdrawn on

This EAMS scientific opinion has been expired as the product was granted a full marketing authorisation.

Information on the EAMS scientific opinion given to sacubitril/valsartan, including the public assessment report.